ORG Wealth Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Buy
1,853
+4
+0.2% +$600 0.04% 214
2026
Q1
$282K Buy
1,849
+33
+2% +$5.06K 0.06% 184
2025
Q4
$250K Hold
1,816
0.06% 178
2025
Q3
$233K Buy
+1,816
New +$222K 0.05% 189
2025
Q1
Sell
-33
Closed -$3.21K 794
2024
Q4
$3.21K Hold
33
﹤0.01% 455
2024
Q3
$3.79K Buy
+33
New +$3.74K ﹤0.01% 418

Other funds holding NVS

ORG Wealth Partners's NVS Position: Q2 2026 in Review

ORG Wealth Partners increased its Novartis (NVS) stake by 0.22% in Q2 2026, buying an estimated $600 and bringing the position to 1,853 shares worth $290K. The position accounts for 0.04% of the portfolio, ranked #214.

ORG Wealth Partners first reported a position in NVS in Q3 2024 and has held it in 6 quarters since. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • ORG Wealth Partners held 1,853 shares of Novartis worth $290K as of Q2 2026.
  • ORG Wealth Partners bought 4 Novartis shares in Q2 2026, an estimated $600.
  • Novartis made up 0.04% of ORG Wealth Partners's portfolio in Q2 2026, its #214 holding.
  • ORG Wealth Partners first reported a position in Novartis in Q3 2024 and has held it in 6 quarters since.
  • 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on ORG Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.